GB00BN7SWP63
|
GSK PLC
|
UK
|
An acquisition or disposal of voting rights
|
GSK plc
|
BRENTFORD
|
United Kingdom
|
|
|
|
23-Nov-2023
|
23-Nov-2023
|
|
% of voting rights attached to shares (total of 8.A)
|
% of voting rights through financial instruments (total of 8.B 1 +
8.B 2)
|
Total of both in % (8.A + 8.B)
|
Total number of voting rights held in issuer
|
Resulting
situation on the date on which threshold was crossed or
reached
|
4.812370
|
0.000000
|
4.812370
|
197068169
|
Position
of previous notification (if applicable)
|
|
|
|
|
Class/Type of shares ISIN code(if possible)
|
Number of direct voting rights (DTR5.1)
|
Number of indirect voting rights (DTR5.2.1)
|
% of direct voting rights (DTR5.1)
|
% of indirect voting rights (DTR5.2.1)
|
GB00BN7SWP63
|
197068169
|
|
4.812370
|
|
Sub
Total 8.A
|
197068169
|
4.812370%
|
Type of financial instrument
|
Expiration date
|
Exercise/conversion period
|
Number of voting rights that may be acquired if the instrument is
exercised/converted
|
% of voting rights
|
|
|
|
|
|
Sub
Total 8.B1
|
|
|
|
Type of financial instrument
|
Expiration date
|
Exercise/conversion period
|
Physical or cash settlement
|
Number of voting rights
|
% of voting rights
|
|
|
|
|
|
|
Sub
Total 8.B2
|
|
|
|
Ultimate controlling person
|
Name of controlled undertaking
|
% of voting rights if it equals or is higher than the notifiable
threshold
|
% of voting rights through financial instruments if it equals or is
higher than the notifiable threshold
|
Total of both if it equals or is higher than the notifiable
threshold
|
|
|
|
|
|
|
|
|
The notification relates to the transfer at market value of 20.0
million treasury shares held by GSK plc to GSK plc's UK Employee
Share Ownership Trust required to meet the expected requirement
arising from awards made under GSK plc's Long Term Incentive Plan
until 2026 vestings.
Please note, the total amount of voting rights has been rounded to
6 decimal places therefore there is a possibility of a rounding
error.
|
29-Nov-2023
|
London
|
|
GSK plc
|
|
(Registrant)
|
|
|
Date: November
29, 2023
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GSK plc
|